Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma

Head and Neck

Volumn 18, Issue 6, 1996, Pages 512-521

  Davidson, Bruce J ^a,b   Lydiatt, William M ^a   Abate, Megan P ^a   Schantz, Stimson P ^a   Chaganti, R S K ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE;

ARTICLE; CANCER RISK; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TOBACCO;

EID: 0029796742     PISSN: 01486403     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0347(199611/12)18:6<512::aid-hed5>3.0.co;2-5     Document Type: Article

References (35)

1. Somers, KD, Cartwright, SL, and Schecter GL. Amplification of the int-2 gene in human head and neck squamous cell carcinomas. Oncogene 1990;5:915-920.
2. Schuuring E, Verhoeven E, Mooi, WJ, and Michalides R. Identification and cloning of two overexpressed genes, U21B31/Prad1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 1992;7:355-361.
3. Faust JB and Meeker TC. Amplification and expression of the bcl-1 gene in human solid tumor cell lines. Cancer Res 1992;52:2460-2463.
4. Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, and Cardesa A. PRAD- 1/Cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 1994;54:4813-4817.
5. Buckley MF, Sweeney KJE, Hamiltin JA, Sim RL, Manning DL, Nicholson RI, deFazio A, Watts CKW, Musgrove EA, and Sutherland RL. Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993;8:22127-22133.
6. Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, and Peters G. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994;54.1812-1817.
7. Bartakova J, Lukas J, Muller H, Lutzhoft D, Strauss M, and Bartek J. Cyclin D1 protein expression and function in human breast cancer. Int. J Cancer 1994;57:353-361.
8. Baldin V, Likas MJ, Marcote M, Pagano J, Bartek J, and Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes and Dev 1993;7:812-821.
9. Quelle DE, Ashmun RA, Shurtleff SA, Kato J, et al. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes and Dev 1993;7:1559-1571.
10. Jiang W, Kahn SM, Zhou P, Zhang Y, Cacace AM, Infante AS, Doi S, Santella RM, and Weinstein IB. Overexpression of Cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 1993;8:3447-3457.
11. Rosenberg CL, Kim HG, Shows TB, Kronenberg HM, and Arnold A. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene 1991;6:2034-2040.
12. Rosenberg CL, Wong E, Petty EM, Bale AE, Tsujimoto Y, Harris NL, and Arnold A. PRAD1, a candidate BCL1 oncogene: Mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci 1991;88:9638-9642
13. Schuuring E, Verhoeven E, Litvinov S, and Michalides R. The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites. Mol Cell Biol 1993;13:2891-2898.
14. Lammie GA, Fantl V, Smith R, Schuuring E, Brooker S, Michalides R, Dickson C, Arnold A, and Peters G. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL1. Oncogene 1991; 6:439-444.
15. Jiang W, Kahn SM, Tomita N, Zhang Y, Lu S, and Weinstein B. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 1992; 52:2980-2983.
16. Bianchi AB, Fischer SM, Robles AI, Rinchik EM, and Conti CJ. Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene 1993;8:1127-1133.
17. Henry JA, Hennessy C, Levett DL, Lennard TWJ, Westley BR, and May FEB. Int-2 amplification in breast cancer: association with decreased survival and relationship to amplification of c-erb-2 and c-myc. Int J Cancer 1993;53:774-780.
18. Schuuring E, Verhoeven E, Van Tinteren H, Peterse JL, Nunnink B, Thunnissen BJM, Devilee P, Cornilisse CJ, Vijver M, Mooi WJ, and Michalides R. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res 1992;52:5229-5234.
19. Williams ME, Gaffey MJ, Weiss LM, Wilczynski SP, Schuuring E, and Levine PA. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1993;119:1238-1243.
20. Meredith SD, Levine PA, Burns JA, Gaffey MJ, Boyd JC, Weiss LM, Erickson NL, and Williams ME. Chromosome 11q13 amplification in head and neck squamous cell carcinoma: association with poor prognosis. Arch Otolaryngol Head Neck Surg 1995;121:790-794.
21. Volling P, Jungehulsing M, Jucker M, Stutzer H, Diehl V, and Tesch H. Coamplification of the hst and bcl-1 oncogenes in advanced squamous cell carcinomas of the head and neck. Eur J Cancer 1993;29A:383-389
22. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor; Cold Spring Harbor Laboratory Press, 1989.
23. Schantz SP, Racz T, Ordonez NG, Terry N, Taylor DL, Bugis S, and Sacks PG. Differential sensitivity of head and neck cancers to non-major histocompatibilityrestricted killer cell activity. J Surg Res 1990;48:154-164.
24. Xu L, Davidson BJ, Murty VVVS, Li R-G, Sacks PG, Garin-Chesa P, Schanz SP, and Chaganti RSK. TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines. Int J Cancer 1994;59:383-387.
25. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, and Arnold A. A novel cyclin encoded by a bcl-1 linked candidate oncogene. Nature 1991; 350.512-515.
26. Ravetch JV, Siebenlist U, Korsmeyer S, Waldman T, and Leder P. Structure of the human immunoglobulin u locus; Characterization of embryonic and rearranged J and D genes. Cell 1981;27:583-591.
27. Dmitrovsky E, Murty VVVS, Moy D, Miller WH, Nanus D, Albino AP, Samaniego F, Bosl G, and Chaganti RSK. Isochrome 12p in non-seminoa cell lines: karyologic amplification of ki-ras2 without point mutation. Oncogene 1990;5:543-548.
28. Casey G, Smith R, McGillivray D, Peters G, and Dickson C. Characterization and chromosome assignment of the human homolog of int-2, a potential proto-oncogene. Mol Cell Biol 1986;6:502-510.
29. Mathew S, Murty VVVS, Dalla-Favera R, and Chaganti RSK, Chromosomal localization of genes encoding the transcription factors c-rel, NF-kBp50, NF-kBp65, lyt-10 by fluorescence in situ hybridization. Oncogene 1993; 8:191-193.
30. Liscia DS, Merlo GR, Garrett C, French D, Mariani-Costantini R, and Callahan R. Expression of int-2 mRNA in human tumors amplified at the int-2 locus. Oncogene 1990;4:1219-1224.
31. Roh HJ, Shin DM, Lee JS, Ro JY, Tainsky MA, Hong WK, and Hittelman WN. Visualization of int-2 amplification in premalignant lesions during head and neck tumorigenesis. Proc AACR 1994;35:117.
32. Kao-Shan C, Fine RL, Whang-Peng J, Lee EC, and Chabner BA. Increased fragile sites and sister chromatid exchanges in bone marrow and peripheral blood of young cigarette smokers. Cancer Res 1987;47:6278-6282.
33. Robles AI, Majeski P, Bauer P, Caamano J, Ruggeri B, Fischer B, Conti CJ, and Klein-Szanto, AJP. Murine skin tumor induced by Benzol(a)pyrene do not show Ha-ras and Cyclin D abnormalities. Proc Am Assoc Cancer Res 1993;34:102.
34. Callender T, El-Naggar AK, Lee MS, Frankenthaler R, Luna MA, and Batsakis JG. PRAD-1 (CCND1)/Cyclin D1 Oncogene Amplification in Primary Head and Neck Squamous Cell Carcinoma. Cancer 1994;74:152-158.
35. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, and Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 1995; 55:975-978.